Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
AVGR - Avinger Inc - Stock Price Chart
TickerAVGR [NASD]
CompanyAvinger Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap3.50MEPS (ttm)-19.48
P/E-EPS this Y91.08%
Forward P/E-EPS next Y35.10%
PEG-EPS past 5Y70.26%
P/S0.46EPS next 5Y-
P/B-EPS Q/Q64.67%
Dividend-Sales Q/Q-1.54%
Insider Own14.08%Inst Own1.84%
Insider Trans0.00%Inst Trans-
Short Float1.10%EarningsMay 15/a
Analyst Recom1.00Target Price5.00
Avg Volume42.47K52W Range2.27 - 18.00
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
YYGH - YY Group Holding Ltd - Stock Price Chart
TickerYYGH [NASD]
CompanyYY Group Holding Ltd
CountrySingapore
IndustryPersonal Services
Market Cap46.91MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own82.07%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.75%Earnings-
Analyst Recom-Target Price-
Avg Volume957.05K52W Range1.20 - 4.70
YY Group Holding Ltd. operates as a holding company with interests in employment services. It offers a job matching portal which provides enterprise manpower outsourcing and smart cleaning services. The firm's services include ad-hoc jobs, full time jobs, freelance, YY promotions and YY pay. The company was founded by Fu Xiao Wei and Zhang Fan in December 2010 and is headquartered in Singapore.
AMIX - Autonomix Medical Inc. - Stock Price Chart
TickerAMIX [NASD]
CompanyAutonomix Medical Inc.
CountryUSA
IndustryMedical Devices
Market Cap35.33MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own56.40%Inst Own0.18%
Insider Trans0.00%Inst Trans-
Short Float0.49%Earnings-
Analyst Recom-Target Price-
Avg Volume55.48K52W Range2.03 - 7.60
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on July 10, 2014 and is headquartered in Doylestown, PA.
SBFM - Sunshine Biopharma Inc - Stock Price Chart
TickerSBFM [NASD]
CompanySunshine Biopharma Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap12.02MEPS (ttm)-13.33
P/E-EPS this Y99.95%
Forward P/E1.06EPS next Y6100.00%
PEG-EPS past 5Y73.50%
P/S0.45EPS next 5Y-
P/B0.03EPS Q/Q74.09%
Dividend-Sales Q/Q54.09%
Insider Own4.14%Inst Own0.78%
Insider Trans18.06%Inst Trans-44.84%
Short Float0.97%EarningsMar 28/b
Analyst Recom1.00Target Price15.00
Avg Volume3.14M52W Range0.69 - 67.01
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerMar 04 '24Buy0.10100,00010,000130,000Mar 05 04:05 PM
Slilaty Steve N.Chief Executive OfficerFeb 08 '24Buy0.1020,0002,00030,000Feb 12 04:05 PM
LAC - Lithium Americas Corp (NewCo) - Stock Price Chart
TickerLAC [NYSE]
CompanyLithium Americas Corp (NewCo)
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap727.52MEPS (ttm)-0.09
P/E-EPS this Y-595.00%
Forward P/E-EPS next Y-68.00%
PEG-EPS past 5Y40.15%
P/S-EPS next 5Y-
P/B1.34EPS Q/Q74.78%
Dividend-Sales Q/Q-
Insider Own19.46%Inst Own10.84%
Insider Trans0.00%Inst Trans-
Short Float9.31%EarningsMay 13/b
Analyst Recom1.69Target Price8.33
Avg Volume5.45M52W Range3.61 - 12.38
Lithium Americas Corp. owns and operates the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company is headquartered in Vancouver, Canada.
VOR - Vor Biopharma Inc - Stock Price Chart
TickerVOR [NASD, RUT]
CompanyVor Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap96.25MEPS (ttm)-1.78
P/E-EPS this Y8.19%
Forward P/E-EPS next Y14.73%
PEG-EPS past 5Y-73.43%
P/S-EPS next 5Y-
P/B0.78EPS Q/Q-5.52%
Dividend-Sales Q/Q-
Insider Own13.44%Inst Own75.63%
Insider Trans0.00%Inst Trans1.19%
Short Float5.91%EarningsMay 09/a
Analyst Recom1.25Target Price14.06
Avg Volume298.06K52W Range1.49 - 5.70
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
PMCB - PharmaCyte Biotech Inc - Stock Price Chart
TickerPMCB [NASD]
CompanyPharmaCyte Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap16.73MEPS (ttm)-1.20
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y56.96%
P/S-EPS next 5Y-
P/B0.54EPS Q/Q-1524.38%
Dividend-Sales Q/Q-
Insider Own10.07%Inst Own11.63%
Insider Trans0.00%Inst Trans65.97%
Short Float0.17%Earnings-
Analyst Recom-Target Price-
Avg Volume24.17K52W Range1.92 - 3.23
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD, RUT]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap43.39MEPS (ttm)0.91
P/E3.67EPS this Y-
Forward P/E-EPS next Y-
PEG1.36EPS past 5Y-3.56%
P/S0.17EPS next 5Y2.70%
P/B0.17EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own81.50%
Insider Trans0.00%Inst Trans-1.44%
Short Float9.96%EarningsNov 16/b
Analyst Recom3.00Target Price17.00
Avg Volume149.08K52W Range3.50 - 23.52
May-22-24 09:00AM Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq (GlobeNewswire) -12.81%
Apr-30-24 08:00AM Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Jan-12-24 10:12AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM
NUKK - Nukkleus Inc - Stock Price Chart
TickerNUKK [NASD]
CompanyNukkleus Inc
CountryUSA
IndustrySoftware - Application
Market Cap2.13MEPS (ttm)-0.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q63.14%
Dividend-Sales Q/Q-
Insider Own79.68%Inst Own8.92%
Insider Trans0.00%Inst Trans-72.00%
Short Float28.12%Earnings-
Analyst Recom-Target Price-
Avg Volume921.85K52W Range0.76 - 10.99
Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. The firm also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. The company is headquartered in Jersey City, NJ.
NUVO - Holdco Nuvo Group D.G Ltd. - Stock Price Chart
TickerNUVO [NASD]
CompanyHoldco Nuvo Group D.G Ltd.
CountryIsrael
IndustryMedical Devices
Market Cap17.36MEPS (ttm)-0.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.28EPS Q/Q-116.00%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own8.13%
Insider Trans-Inst Trans5.93%
Short Float0.67%Earnings-
Analyst Recom-Target Price-
Avg Volume877.15K52W Range1.48 - 21.50
Holdco Nuvo Group DG Ltd. engages in the provision of fetal monitoring solutions for pregnancy care. It develops INVU platform, a proprietary self-administered wireless sensor band to capture real-time data on key maternal and fetal health metrics. The company was founded on July 20, 2023 and is headquartered in Tel Aviv, Israel.
12345671020